$HSTM
HealthStream Inc

2014 Q1 Form 10-Q Financial Statement

#000119312514176008 Filed on May 01, 2014

View on sec.gov

Income Statement

Concept 2014 Q1 2013 Q1
Revenue $38.35M $29.65M
YoY Change 29.36% 25.25%
Cost Of Revenue $16.93M $12.52M
YoY Change 35.19% 30.69%
Gross Profit $21.42M $17.13M
YoY Change 25.1% 21.46%
Gross Profit Margin 55.86% 57.77%
Selling, General & Admin $12.18M $9.471M
YoY Change 28.59% 13.29%
% of Gross Profit 56.85% 55.3%
Research & Development $3.546M $2.606M
YoY Change 36.07% 39.36%
% of Gross Profit 16.55% 15.22%
Depreciation & Amortization $2.401M $1.876M
YoY Change 27.99% 22.61%
% of Gross Profit 11.21% 10.95%
Operating Expenses $15.73M $12.08M
YoY Change 30.21% 2.78%
Operating Profit $3.298M $3.173M
YoY Change 3.94% 35.02%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $45.00K $47.00K
YoY Change -4.26%
Pretax Income $3.343M $3.220M
YoY Change 3.82% 36.44%
Income Tax $1.395M $1.279M
% Of Pretax Income 41.73% 39.72%
Net Earnings $1.948M $1.941M
YoY Change 0.36% 36.69%
Net Earnings / Revenue 5.08% 6.55%
Basic Earnings Per Share $0.07 $0.07
Diluted Earnings Per Share $0.07 $0.07
COMMON SHARES
Basic Shares Outstanding 27.45M shares 26.34M shares
Diluted Shares Outstanding 27.91M shares 27.41M shares

Balance Sheet

Concept 2014 Q1 2013 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $102.0M $95.60M
YoY Change 6.69% 11.68%
Cash & Equivalents $59.05M $43.89M
Short-Term Investments $43.00M $51.70M
Other Short-Term Assets $3.231M $5.800M
YoY Change -44.29% -26.58%
Inventory
Prepaid Expenses
Receivables $32.07M $24.00M
Other Receivables $0.00 $0.00
Total Short-Term Assets $150.3M $125.3M
YoY Change 19.91% 12.98%
LONG-TERM ASSETS
Property, Plant & Equipment $9.189M $7.800M
YoY Change 17.81% 25.81%
Goodwill $42.75M
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $995.0K $600.0K
YoY Change 65.83% -90.0%
Total Long-Term Assets $80.71M $56.40M
YoY Change 43.1% 29.66%
TOTAL ASSETS
Total Short-Term Assets $150.3M $125.3M
Total Long-Term Assets $80.71M $56.40M
Total Assets $231.0M $181.7M
YoY Change 27.11% 17.68%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.914M $1.300M
YoY Change 124.15% -7.14%
Accrued Expenses $6.948M $9.600M
YoY Change -27.63% 108.7%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $69.72M $39.30M
YoY Change 77.4% 30.13%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $750.0K $700.0K
YoY Change 7.14% 16.67%
Total Long-Term Liabilities $750.0K $700.0K
YoY Change 7.14% 16.67%
TOTAL LIABILITIES
Total Short-Term Liabilities $69.72M $39.30M
Total Long-Term Liabilities $750.0K $700.0K
Total Liabilities $70.47M $46.50M
YoY Change 51.55% 49.04%
SHAREHOLDERS EQUITY
Retained Earnings -$15.48M
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $154.3M $135.2M
YoY Change
Total Liabilities & Shareholders Equity $231.0M $181.7M
YoY Change 27.11% 17.68%

Cashflow Statement

Concept 2014 Q1 2013 Q1
OPERATING ACTIVITIES
Net Income $1.948M $1.941M
YoY Change 0.36% 36.69%
Depreciation, Depletion And Amortization $2.401M $1.876M
YoY Change 27.99% 22.61%
Cash From Operating Activities $9.190M $3.860M
YoY Change 138.08% 13.2%
INVESTING ACTIVITIES
Capital Expenditures $1.104M $744.0K
YoY Change 48.39% -142.27%
Acquisitions $12.50M $181.0K
YoY Change 6806.63%
Other Investing Activities -$7.410M -$260.0K
YoY Change 2750.0% -99.53%
Cash From Investing Activities -$9.980M -$2.070M
YoY Change 382.13% -96.35%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 290.0K 740.0K
YoY Change -60.81% 23.33%
NET CHANGE
Cash From Operating Activities 9.190M 3.860M
Cash From Investing Activities -9.980M -2.070M
Cash From Financing Activities 290.0K 740.0K
Net Change In Cash -500.0K 2.530M
YoY Change -119.76% -104.81%
FREE CASH FLOW
Cash From Operating Activities $9.190M $3.860M
Capital Expenditures $1.104M $744.0K
Free Cash Flow $8.086M $3.116M
YoY Change 159.5% -39.73%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2014Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
27564606 shares
CY2013Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
43888000
CY2014Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
27565000 shares
CY2014Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
27565000 shares
CY2014Q1 us-gaap Common Stock No Par Value
CommonStockNoParValue
CY2014Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2014Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
6948000
CY2014Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
22918000
CY2014Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
2914000
CY2014Q1 us-gaap Capitalized Computer Software Accumulated Amortization
CapitalizedComputerSoftwareAccumulatedAmortization
14844000
CY2014Q1 us-gaap Deferred Tax Liabilities Current
DeferredTaxLiabilitiesCurrent
181000
CY2014Q1 us-gaap Liabilities Current
LiabilitiesCurrent
69719000
CY2014Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-23000
CY2014Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1291000
CY2014Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
750000
CY2014Q1 us-gaap Stockholders Equity
StockholdersEquity
154317000
CY2014Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
276000
CY2014Q1 us-gaap Common Stocks Including Additional Paid In Capital
CommonStocksIncludingAdditionalPaidInCapital
169816000
CY2014Q1 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
10907000
CY2014Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-15476000
CY2014Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
47478000
CY2014Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
11867000
CY2014Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
230959000
CY2014Q1 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
6173000
CY2014Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2014Q1 us-gaap Assets Current
AssetsCurrent
150251000
CY2014Q1 us-gaap Goodwill
Goodwill
42749000
CY2014Q1 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
5806000
CY2014Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
995000
CY2014Q1 us-gaap Assets
Assets
230959000
CY2014Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
59045000
CY2014Q1 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
4138000
CY2014Q1 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
11783000
CY2014Q1 us-gaap Receivables Long Term Contracts Or Programs
ReceivablesLongTermContractsOrPrograms
1427000
CY2014Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
32073000
CY2014Q1 us-gaap Prepaid Royalties
PrepaidRoyalties
11523000
CY2014Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
32107000
CY2014Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
15992000
CY2014Q1 us-gaap Available For Sale Securities
AvailableForSaleSecurities
42952000
CY2014Q1 us-gaap Other Assets Current
OtherAssetsCurrent
3231000
CY2014Q1 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
22163000
CY2014Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
9189000
CY2014Q1 hstm Percentage Of Profit Or Loss Received From Collaborative Arrangement
PercentageOfProfitOrLossReceivedFromCollaborativeArrangement
0.50 pure
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
41365000
CY2013Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
27327000 shares
CY2013Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
27327000 shares
CY2013Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
CY2013Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2013Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-31000
CY2013Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1614000
CY2013Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
776000
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
149433000
CY2013Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
211000
CY2013Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5503000
CY2013Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
21968000
CY2013Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2311000
CY2013Q4 us-gaap Capitalized Computer Software Accumulated Amortization
CapitalizedComputerSoftwareAccumulatedAmortization
13910000
CY2013Q4 us-gaap Deferred Tax Liabilities Current
DeferredTaxLiabilitiesCurrent
181000
CY2013Q4 us-gaap Liabilities Current
LiabilitiesCurrent
56212000
CY2013Q4 us-gaap Common Stocks Including Additional Paid In Capital
CommonStocksIncludingAdditionalPaidInCapital
166888000
CY2013Q4 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
8435000
CY2013Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-17424000
CY2013Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
38168000
CY2013Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
11389000
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
212594000
CY2013Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
6173000
CY2013Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2013Q4 us-gaap Assets Current
AssetsCurrent
147124000
CY2013Q4 us-gaap Goodwill
Goodwill
35746000
CY2013Q4 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
5521000
CY2013Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
739000
CY2013Q4 us-gaap Assets
Assets
212594000
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
59537000
CY2013Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
3854000
CY2013Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
11077000
CY2013Q4 us-gaap Receivables Long Term Contracts Or Programs
ReceivablesLongTermContractsOrPrograms
1392000
CY2013Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
25314000
CY2013Q4 us-gaap Prepaid Royalties
PrepaidRoyalties
8857000
CY2013Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
31006000
CY2013Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
8870000
CY2013Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
48659000
CY2013Q4 us-gaap Other Assets Current
OtherAssetsCurrent
3365000
CY2013Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
21631000
CY2013Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
9038000
CY2013Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.07
CY2013Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
27409000 shares
CY2013Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.07
CY2013Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.397 pure
CY2013Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
3855000
CY2013Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1069000 shares
CY2013Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
26340000 shares
CY2013Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
135000 shares
CY2013Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
270000
CY2013Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1931000
CY2013Q1 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
CY2013Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
181000
CY2013Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
47000
CY2013Q1 us-gaap Stock Issued1
StockIssued1
CY2013Q1 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
29552000
CY2013Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-27000
CY2013Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
3173000
CY2013Q1 us-gaap Payments For Software
PaymentsForSoftware
1072000
CY2013Q1 us-gaap Increase Decrease In Prepaid Royalties
IncreaseDecreaseInPrepaidRoyalties
-1652000
CY2013Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
158000
CY2013Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
3220000
CY2013Q1 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
7487000
CY2013Q1 us-gaap Net Income Loss
NetIncomeLoss
1941000
CY2013Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-10000
CY2013Q1 us-gaap Sales Revenue Net
SalesRevenueNet
29646000
CY2013Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
744000
CY2013Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-10000
CY2013Q1 us-gaap Costs And Expenses
CostsAndExpenses
26473000
CY2013Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4272000
CY2013Q1 us-gaap Increase Decrease In Royalties Payable
IncreaseDecreaseInRoyaltiesPayable
-1477000
CY2013Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
742000
CY2013Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
1279000
CY2013Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
5279000
CY2013Q1 us-gaap Share Based Compensation
ShareBasedCompensation
310000
CY2013Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
20000
CY2013Q1 us-gaap Cost Of Goods Sold Excluding Depreciation Depletion And Amortization
CostOfGoodsSoldExcludingDepreciationDepletionAndAmortization
12520000
CY2013Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
2523000
CY2013Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
5199000
CY2013Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-2074000
CY2013Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
167000
CY2013Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
230000
CY2013Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2606000
CY2013Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
900000
CY2013Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1876000
CY2013Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
310000
CY2013Q1 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
29475000
CY2013Q1 us-gaap Other Noncash Expense
OtherNoncashExpense
308000
CY2013Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1279000
CY2013Q1 hstm Revenues Related To Collaborative Arrangement
RevenuesRelatedToCollaborativeArrangement
400000
CY2013Q1 hstm Expenses Related To Collaborative Arrangement
ExpensesRelatedToCollaborativeArrangement
400000
CY2014Q1 dei Entity Registrant Name
EntityRegistrantName
HEALTHSTREAM INC
CY2014Q1 dei Amendment Flag
AmendmentFlag
false
CY2014Q1 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2014Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2014
CY2014Q1 dei Document Type
DocumentType
10-Q
CY2014Q1 dei Document Period End Date
DocumentPeriodEndDate
2014-03-31
CY2014Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001095565
CY2014Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2014Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2014Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.07
CY2014Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
27906000 shares
CY2014Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.07
CY2014Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.417 pure
CY2014Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
9189000
CY2014Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
453000 shares
CY2014Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
27453000 shares
CY2014Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
165000 shares
CY2014Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
297000
CY2014Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-140000
CY2014Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1956000
CY2014Q1 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
250000
CY2014Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
12501000
CY2014Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
45000
CY2014Q1 us-gaap Stock Issued1
StockIssued1
2247000
CY2014Q1 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
13176000
CY2014Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-26000
CY2014Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
3298000
CY2014Q1 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
2247000
CY2014Q1 us-gaap Payments For Software
PaymentsForSoftware
1464000
CY2014Q1 us-gaap Increase Decrease In Prepaid Royalties
IncreaseDecreaseInPrepaidRoyalties
2667000
CY2014Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
152000
CY2014Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
3343000
CY2014Q1 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
5107000
CY2014Q1 us-gaap Net Income Loss
NetIncomeLoss
1948000
CY2014Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
8000
CY2014Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
384000
CY2014Q1 us-gaap Sales Revenue Net
SalesRevenueNet
38350000
CY2014Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1104000
CY2014Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
8000
CY2014Q1 us-gaap Costs And Expenses
CostsAndExpenses
35052000
CY2014Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5232000
CY2014Q1 us-gaap Increase Decrease In Royalties Payable
IncreaseDecreaseInRoyaltiesPayable
2472000
CY2014Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
297000
CY2014Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
1395000
CY2014Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
8599000
CY2014Q1 us-gaap Share Based Compensation
ShareBasedCompensation
384000
CY2014Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
70000
CY2014Q1 us-gaap Cost Of Goods Sold Excluding Depreciation Depletion And Amortization
CostOfGoodsSoldExcludingDepreciationDepletionAndAmortization
16926000
CY2014Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-492000
CY2014Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
6947000
CY2014Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-9978000
CY2014Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-1452000
CY2014Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
604000
CY2014Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3546000
CY2014Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
449000
CY2014Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2401000
CY2014Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
384000
CY2014Q1 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
18517000
CY2014Q1 us-gaap Other Noncash Expense
OtherNoncashExpense
376000
CY2014Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1395000
CY2014Q1 hstm Revenues Related To Collaborative Arrangement
RevenuesRelatedToCollaborativeArrangement
400000
CY2014Q1 hstm Expenses Related To Collaborative Arrangement
ExpensesRelatedToCollaborativeArrangement
500000
CY2014Q1 hstm Number Of Stock Incentive Plans
NumberOfStockIncentivePlans
2 Incentive_Plan

Files In Submission

Name View Source Status
0001193125-14-176008-index-headers.html Edgar Link pending
0001193125-14-176008-index.html Edgar Link pending
0001193125-14-176008.txt Edgar Link pending
0001193125-14-176008-xbrl.zip Edgar Link pending
d699064d10q.htm Edgar Link pending
d699064dex311.htm Edgar Link pending
d699064dex312.htm Edgar Link pending
d699064dex321.htm Edgar Link pending
d699064dex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
hstm-20140331.xml Edgar Link completed
hstm-20140331.xsd Edgar Link pending
hstm-20140331_cal.xml Edgar Link unprocessable
hstm-20140331_def.xml Edgar Link unprocessable
hstm-20140331_lab.xml Edgar Link unprocessable
hstm-20140331_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending